Evidence map›Paper›PMID 26699484›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

The histone H2A deubiquitinase Usp16 regulates hematopoiesis and hematopoietic stem cell function.

Yue Gu, Amanda E Jones, Wei Yang, Shanrun Liu, Qian Dai, Yudong Liu, C Scott Swindle, Dewang Zhou, Zhuo Zhang, Thomas M Ryan and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Yue GuDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294;
Amanda E JonesDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294;
Wei YangDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294;
Shanrun LiuDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294;
Qian DaiDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294;
Yudong LiuDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294;
C Scott SwindleDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294;
Dewang ZhouDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294;
Zhuo ZhangDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294;
Thomas M RyanDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294;
Tim M TownesDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294;
Christopher A KlugDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294;
Dongquan ChenDivision of Preventive Medicine, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294.
Hengbin WangDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294; hbwang@uab.edu.
University of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI GARY O RANKIN · 2012 to 2026
$61.1M
Role of Ubp-M and H2A deubiquitination in chromatin and cellular functionR01GM081489 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WANG, HENGBIN · 2008 to 2012
$1.5M
NCI NIH HHS P30 CA013148NIGMS NIH HHS P20 GM103434NIGMS NIH HHS R01 GM081489
6 · The paper itself

Abstract

Epigenetic mechanisms play important regulatory roles in hematopoiesis and hematopoietic stem cell (HSC) function. Subunits of polycomb repressive complex 1 (PRC1), the major histone H2A ubiquitin ligase, are critical for both normal and pathological hematopoiesis; however, it is unclear which of the several counteracting H2A deubiquitinases functions along with PRC1 to control H2A ubiquitination (ubH2A) level and regulates hematopoiesis in vivo. Here we investigated the function of Usp16 in mouse hematopoiesis. Conditional deletion of Usp16 in bone marrow resulted in a significant increase of global ubH2A level and lethality. Usp16 deletion did not change HSC number but was associated with a dramatic reduction of mature and progenitor cell populations, revealing a role in governing HSC lineage commitment. ChIP- and RNA-sequencing studies in HSC and progenitor cells revealed that Usp16 bound to many important hematopoietic regulators and that Usp16 deletion altered the expression of genes in transcription/chromosome organization, immune response, hematopoietic/lymphoid organ development, and myeloid/leukocyte differentiation. The altered gene expression was partly rescued by knockdown of PRC1 subunits, suggesting that Usp16 and PRC1 counterbalance each other to regulate cellular ubH2A level and gene expression in the hematopoietic system. We further discovered that knocking down Cdkn1a (p21cip1), a Usp16 target and regulated gene, rescued the altered cell cycle profile and differentiation defect of Usp16-deleted HSCs. Collectively, these studies identified Usp16 as one of the histone H2A deubiquitinases, which coordinates with the H2A ubiquitin ligase PRC1 to regulate hematopoiesis, and revealed cell cycle regulation by Usp16 as key for HSC differentiation.

Indexed as

AnimalsCell CountCyclin-Dependent Kinase Inhibitor p21EndopeptidasesGene Expression RegulationGene Knockdown TechniquesGenes, LethalHematopoiesisHematopoietic Stem CellsHistonesMiceMice, Inbred C57BLPolycomb-Group ProteinsTrans-ActivatorsUbiquitin-Specific ProteasesUbiquitin ThiolesteraseCdkn1a protein, mouseCyclin-Dependent Kinase Inhibitor p21EndopeptidasesHistonesMYSM1 protein, mousePolycomb-Group ProteinsTrans-ActivatorsUbiquitin-Specific ProteasesUbiquitin ThiolesteraseUsp16 protein, mouseH2A deubiquitinationhematopoiesishematopoietic stem cellpolycomb repressive complex 1Usp16

Identifiers

PMID26699484
PMCPMC4711844
OpenAlexW2198414929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.